Global Lung Cancer Diagnostic And Screening Market Report 2024

Lung Cancer Diagnostic And Screening Global Market Report 2024 – By Product (Instruments, Consumables And Accessories), By Test (Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests), By Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), By End User (Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Lung Cancer Diagnostic And Screening Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Lung Cancer Diagnostic And Screening Market Definition And Segments

Lung cancer diagnosis and screening refers to using examinations and techniques to discover and identify lung cancer in people with the goal of early detection and precise diagnosis for efficient treatment planning. It is commonly used to treat squamous cell carcinomas, adenocarcinoma, and large cell carcinoma.

The main products of lung cancer diagnostics and screening are instruments, consumables, and accessories. An instrument refers to products that are used to read or analyze the results of a diagnostic product, and process samples for a diagnostic product. The various tests include biomarkers tests, imaging tests, biopsy, blood tests, and others used for various cancer types such as non-small cell lung cancer, and small cell lung cancer. These are used by various end-users such as hospitals, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others.

The lung cancer diagnostic and screening market covered in this report is segmented –

1) By Product: Instruments, Consumables And Accessories

2) By Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests

3) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

4) By End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users

The lung cancer diagnostic and screening market size has grown rapidly in recent years. It will grow from $2.11 billion in 2023 to $2.32 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to growth in digital imaging, standardization of screening protocols, public health initiatives against tobacco use, establishment of cancer registries, and advancements in pathology analysis.

The lung cancer diagnostic and screening market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing incidence of lung cancer, growing emphasis on early detection, expansion of high-risk screening programs, shift towards personalized medicine, government initiatives and funding. Major trends in the forecast period include emergence of novel screening modalities, advancements in biomarker testing, integration of artificial intelligence (AI), rise in liquid biopsy adoption, focus on early stage detection, and expansion of low-dose CT screening programs.

Surging Prevalence Of Lung Cancer Drives Expansion In The Lung Cancer Diagnostic And Screening Market

The increasing prevalence of lung cancer is expected to propel the growth of the lung cancer diagnostic and screening market going forward. Lung cancer is a malignant disease with symptoms such as coughing, chest pain, and difficulty breathing that is defined by the unchecked proliferation of abnormal cells in the lung tissues. Lung cancer diagnosis and screening help lung cancer patients early diagnose the disease with various tests, including an incisional biopsy and a bronchoscopy. For instance, in January 2023, according to the American Cancer Society, a US-based government organization, in the United States, there were approximately 238,340 new cases of lung cancer (117,550 in men and 120,790 in women). Further, there were reportedly 127,070 deaths from lung cancer (67,160 in men and 59,910 in women). Therefore, the rise in the prevalence of lung cancer is driving the growth of the lung cancer diagnostic and screening market.

Rising Healthcare Expenditures Is Anticipated To Fuel The Lung Cancer Diagnostic And Screening Market

The rising healthcare expenditures are expected to propel the growth of the lung cancer diagnostic and screening market going forward. Healthcare expenditures refer to the total costs incurred by individuals, governments, or organizations in providing and receiving medical services, treatments, and healthcare-related goods and activities. Lung cancer diagnostic and screening methods contribute to healthcare expenditures by providing early detection opportunities, potentially reducing long-term treatment costs, and improving patient outcomes. For instance, in November 2022, according to the CIHI, a Canada-based Institute for Health Information, forecasted that total health spending in Canada is expected to rise by 0.8% from $328 billion in 2021 to $331 billion in 2022. Therefore, rising healthcare expenditures are driving the lung cancer diagnostic and screening market.

Major companies operating in the lung cancer diagnostic and screening market report are Pfizer Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories Inc., Medtronic Plc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, Eon Health Inc., OncimmuneHoldings PLC, Broncus Medical Inc., OncoCyte, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix, iDNA

Technological Innovations Reshape Landscape Of Lung Cancer Diagnostics And Screening Market

Technological innovations are a key trend gaining popularity in the lung cancer diagnostics and screening market. Major companies operating in the lung cancer diagnostics and screening market are introducing innovative technologies to sustain their position in the market. For instance, in December 2021, Auris Health, a US-based robotic medical company, introduced the MONARCH Robotic-Assisted Bronchoscopy procedure, the first MONARCH procedure. This procedure allows physicians to accurately diagnose small and hard-to-reach lung nodules, which enables biopsy for early diagnosis and treatment of lung disease.

Blood-Based Test To Provide Accessible And Convenient Lung Cancer Screening

Major companies in the lung cancer diagnostic and screening market are focused on developing a blood-based test that utilizes machine learning, such as whole-genome machine learning, to provide accessible and convenient lung cancer screening and gain a competitive edge in the market. Whole-genome machine learning refers to the application of machine learning algorithms to analyze and interpret comprehensive sets of genetic information, encompassing an organism's entire genome. For instance, in October 2023, DELFI Diagnostics Inc., a US-based developer of accessible blood-based tests, launched FirstLook Lung, a blood test using whole-genome machine learning to analyze cell-free DNA fragments, enhancing lung cancer screening with a 99.7% NPV. The test, designed for routine blood work, identifies individuals with potential lung cancer, including early-stage disease. Addressing low LDCT screening uptake, the test aims to improve population health.

RadNet Inc Strengthens AI Capabilities With Acquisition Of Aidence Bv

In January 2022, RadNet Inc., a US-based radiology company, acquired Aidence BV for an undisclosed amount. The acquisition is expected to enhance RadNet Inc.'s leadership in developing and deploying AI to improve patient care and health and accelerate growth and innovation pipeline to provide automated and integrated AI oncology solutions for clinicians. Aidence BV is a Netherlands-based healthcare technology company focusing on clinical solutions for lung cancer screening and pulmonary nodule treatment.

North America was the largest region in the lung cancer diagnostic and screening market in 2023. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lung cancer diagnostic and screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lung cancer diagnosis and screening market consists of revenues earned by entities by providing positron emission tomography (PET) scanners, and bronchoscopy. The market value includes the value of related goods sold by the service provider or included within the service offering. The lung cancer diagnosis and screening market also includes sales of products such as liquid biopsy kits, molecular testing kits, and biopsy tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The lung cancer diagnostics and screening market research report are one of a series of new reports from The Business Research Company that provides lung cancer diagnostics and screening market statistics, including lung cancer diagnostics and screening industry global market size, regional shares, competitors with a lung cancer diagnostics and screening market share, detailed lung cancer diagnostics and screening market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer diagnostics and screening industry. This lung cancer diagnostics and screening market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Lung Cancer Diagnostic And Screening Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.32 billion
Revenue Forecast In 2033 $3.3 billion
Growth Rate CAGR of 9.2% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Instruments, Consumables And Accessories
2) By Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests
3) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
4) By End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; F. Hoffmann-La Roche AG; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; AstraZeneca Plc; Abbott Laboratories Inc.; Medtronic Plc.; Danaher Corporation; Siemens Healthcare GmbH; FUJIFILM Corporation; Koninklijke Philips N.V.; GE Healthcare Bio Sciences AB; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; Qiagen Inc.; Myriad Genetic Laboratories Inc.; NeoGenomics Laboratories Inc.; Canon Medical Systems Corporation; Eon Health Inc.; OncimmuneHoldings Plc; Broncus Medical Inc.; OncoCyte; Riverain Technologies LLC; VisionGate; Foundation Medicine Inc.; Biodesix; iDNA
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Lung Cancer Diagnostic And Screening Market Characteristics

    3. Lung Cancer Diagnostic And Screening Market Trends And Strategies

    4. Lung Cancer Diagnostic And Screening Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Lung Cancer Diagnostic And Screening Market Size and Growth

    5.1. Global Lung Cancer Diagnostic And Screening Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Lung Cancer Diagnostic And Screening Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Lung Cancer Diagnostic And Screening Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Lung Cancer Diagnostic And Screening Market Segmentation

    6.1. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Instruments

    Consumables And Accessories

    6.2. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Biomarkers Tests

    Imaging Test

    Biopsy

    Blood Test

    Other Tests

    6.3. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Non-Small Cell Lung Cancer

    Small Cell Lung Cancer

    6.4. Global Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital

    Independent Diagnostic Laboratories

    Diagnostic Imaging Centers

    Cancer Research Institutes

    Other End-Users

    7. Lung Cancer Diagnostic And Screening Market Regional And Country Analysis

    7.1. Global Lung Cancer Diagnostic And Screening Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Lung Cancer Diagnostic And Screening Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Lung Cancer Diagnostic And Screening Market

    8.1. Asia-Pacific Lung Cancer Diagnostic And Screening Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Lung Cancer Diagnostic And Screening Market

    9.1. China Lung Cancer Diagnostic And Screening Market Overview

    9.2. China Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Lung Cancer Diagnostic And Screening Market

    10.1. India Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Lung Cancer Diagnostic And Screening Market

    11.1. Japan Lung Cancer Diagnostic And Screening Market Overview

    11.2. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Lung Cancer Diagnostic And Screening Market

    12.1. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Lung Cancer Diagnostic And Screening Market

    13.1. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Lung Cancer Diagnostic And Screening Market

    14.1. South Korea Lung Cancer Diagnostic And Screening Market Overview

    14.2. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Lung Cancer Diagnostic And Screening Market

    15.1. Western Europe Lung Cancer Diagnostic And Screening Market Overview

    15.2. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Lung Cancer Diagnostic And Screening Market

    16.1. UK Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Lung Cancer Diagnostic And Screening Market

    17.1. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Lung Cancer Diagnostic And Screening Market

    18.5. France Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Lung Cancer Diagnostic And Screening Market

    19.9. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Lung Cancer Diagnostic And Screening Market

    20.13. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Lung Cancer Diagnostic And Screening Market

    21.1. Eastern Europe Lung Cancer Diagnostic And Screening Market Overview

    21.2. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Lung Cancer Diagnostic And Screening Market

    22.1. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Lung Cancer Diagnostic And Screening Market

    23.1. North America Lung Cancer Diagnostic And Screening Market Overview

    23.2. North America Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Lung Cancer Diagnostic And Screening Market

    24.1. USA Lung Cancer Diagnostic And Screening Market Overview

    24.2. USA Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Lung Cancer Diagnostic And Screening Market

    25.1. Canada Lung Cancer Diagnostic And Screening Market Overview

    25.2. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Lung Cancer Diagnostic And Screening Market

    26.1. South America Lung Cancer Diagnostic And Screening Market Overview

    26.2. South America Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Lung Cancer Diagnostic And Screening Market

    27.1. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Lung Cancer Diagnostic And Screening Market

    28.1. Middle East Lung Cancer Diagnostic And Screening Market Overview

    28.2. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Lung Cancer Diagnostic And Screening Market

    29.1. Africa Lung Cancer Diagnostic And Screening Market Overview

    29.2. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Lung Cancer Diagnostic And Screening Market Competitive Landscape And Company Profiles

    30.1. Lung Cancer Diagnostic And Screening Market Competitive Landscape

    30.2. Lung Cancer Diagnostic And Screening Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. F. Hoffmann-La Roche AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bristol-Myers Squibb Company

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Thermo Fisher Scientific Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AstraZeneca Plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Lung Cancer Diagnostic And Screening Market Other Major And Innovative Companies

    31.1. Abbott Laboratories Inc.

    31.2. Medtronic Plc.

    31.3. Danaher Corporation

    31.4. Siemens Healthcare GmbH

    31.5. FUJIFILM Corporation

    31.6. Koninklijke Philips N.V.

    31.7. GE Healthcare Bio Sciences AB

    31.8. Quest Diagnostics Incorporated

    31.9. Agilent Technologies Inc.

    31.10. Illumina Inc.

    31.11. Qiagen Inc.

    31.12. Myriad Genetic Laboratories Inc.

    31.13. NeoGenomics Laboratories Inc.

    31.14. Canon Medical Systems Corporation

    31.15. Eon Health Inc.

    32. Global Lung Cancer Diagnostic And Screening Market Competitive Benchmarking

    33. Global Lung Cancer Diagnostic And Screening Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Lung Cancer Diagnostic And Screening Market

    35. Lung Cancer Diagnostic And Screening Market Future Outlook and Potential Analysis

    35.1 Lung Cancer Diagnostic And Screening Market In 2028 - Countries Offering Most New Opportunities

    35.2 Lung Cancer Diagnostic And Screening Market In 2028 - Segments Offering Most New Opportunities

    35.3 Lung Cancer Diagnostic And Screening Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Lung Cancer Diagnostic And Screening Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Lung Cancer Diagnostic And Screening Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: F. Hoffmann-La Roche AG Financial Performance
  • Table 77: Bristol-Myers Squibb Company Financial Performance
  • Table 78: Thermo Fisher Scientific Inc. Financial Performance
  • Table 79: AstraZeneca Plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Lung Cancer Diagnostic And Screening Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Lung Cancer Diagnostic And Screening Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: F. Hoffmann-La Roche AG Financial Performance
  • Figure 77: Bristol-Myers Squibb Company Financial Performance
  • Figure 78: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 79: AstraZeneca Plc Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Cold Chain Packaging Global Market Report 2024 – By Product (Crates, Insulated Container And Boxes, Cold Packs, Label, Temperature Controlled Pallet Shippers), By Material Type (Expanded polystyrene (EPS), Vacuum insulated panel (VIP) solutions, Polyurethane (PUR)), By Application (Fruits And Vegetables, Fruit And Pulp Concentrates, Dairy Products, Fish, Meat And Seafood, Processed Food, Pharmaceuticals, Bakery And Confectionaries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical Logistics Global Market Report 2024 – By Type (Cold Chain Logistics, Non-Cold Chain Logistics), By Component (Storage, Transportation, Monitoring Components), By Procedure (Picking, Storage, Retrieval Systems, Handling Systems), By Transportation (Sea Freight, Air Freight, Overland), By Application (Bio Pharma, Chemical Pharma, Specialty Pharma) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Chemicals Global Market Report 2024 – By Type (General Chemical Product, Printing Inks, Toiletries, Soap and Cleaning Compounds, Adhesives, Paints and Coatings, Pesticide and Other Agricultural Chemicals, Chemical Fertilizers, Synthetic Rubber and Fibers, Plastic Material and Resins, Ethyl Alcohol and Other Basic Organic Chemical, Other Basic Inorganic Chemical, Synthetic Dye and Pigment, Industrial Gas, Petrochemicals), By Type of Intermediate Chemicals (Methanol, Ethylene Oxide, Propylene Oxide), By End User (Pharmaceuticals, Agrochemicals, Water Treatment, Construction, Paints and Dyes, Oil & Gas, Rubber Chemicals, Surfactants, Personal Care, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Chemicals Global Market Report 2024 – By Type (General Chemical Product, Printing Inks, Toiletries, Soap and Cleaning Compounds, Adhesives, Paints and Coatings, Pesticide and Other Agricultural Chemicals, Chemical Fertilizers, Synthetic Rubber and Fibers, Plastic Material and Resins, Ethyl Alcohol and Other Basic Organic Chemical, Other Basic Inorganic Chemical, Synthetic Dye and Pigment, Industrial Gas, Petrochemicals), By Type of Intermediate Chemicals (Methanol, Ethylene Oxide, Propylene Oxide), By End User (Pharmaceuticals, Agrochemicals, Water Treatment, Construction, Paints and Dyes, Oil & Gas, Rubber Chemicals, Surfactants, Personal Care, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Personal Services Global Market Report 2024 – By Type (Personal Care Services, Death Care Services, Dry-Cleaning And Laundry Services, Other Personal Services, Private Household Services), By Mode (Online, Offline), By Distribution Channel (Specialist Retail Stores, Supermarkets Hypermarkets, Convenience Stores, Pharmacies Drug Stores, Online Retail Channels, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Toiletries Global Market Report 2024 – By Type (Lotions (Including Sunscreens), Hair Preparations, Face Creams, Perfumes, Shaving Preparations, Other Cosmetic Preparations), By Preference (Mass, Premium), By Gender (Male, Female), By Distribution Channel (Hypermarkets/Supermarkets, E-Commerce, Pharmacy Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Metabolic Disorders Drugs Global Market Report 2022 – By Type (Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Frequently Asked Questions

What is the definition of the lung cancer diagnostic and screening market?

Lung cancer diagnosis and screening refers to using examinations and techniques to discover and identify lung cancer in people with the goal of early detection and precise diagnosis for efficient treatment planning. It is commonly used to treat squamous cell carcinomas, adenocarcinoma, and large cell carcinoma. For further insights on the lung cancer diagnostic and screening market, request a sample here

How will the lung cancer diagnostic and screening market drivers and restraints affect the lung cancer diagnostic and screening market dynamics? What forces will shape the lung cancer diagnostic and screening industry going forward?

The lung cancer diagnostic and screening market major growth driver - Surging Prevalence Of Lung Cancer Drives Expansion In The Lung Cancer Diagnostic And Screening Market. For further insights on the lung cancer diagnostic and screening market, request a sample here

What is the forecast market size or the forecast market value of the lung cancer diagnostic and screening market?

The lung cancer diagnostic and screening market size has grown rapidly in recent years. It will grow from $2.11 billion in 2023 to $2.32 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to growth in digital imaging, standardization of screening protocols, public health initiatives against tobacco use, establishment of cancer registries, advancements in pathology analysis.. The lung cancer diagnostic and screening market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing incidence of lung cancer, growing emphasis on early detection, expansion of high-risk screening programs, shift towards personalized medicine, government initiatives and funding. Major trends in the forecast period include emergence of novel screening modalities, advancements in biomarker testing, integration of artificial intelligence (ai), rise in liquid biopsy adoption, focus on early stage detection, expansion of low-dose ct screening programs. For further insights on the lung cancer diagnostic and screening market, request a sample here

How is the lung cancer diagnostic and screening market segmented?

The lung cancer diagnostic and screening market is segmented
1) By Product: Instruments, Consumables And Accessories
2) By Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests
3) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
4) By End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-UsersFor further insights on the lung cancer diagnostic and screening market, request a sample here

Which region has the largest share of the lung cancer diagnostic and screening market? What are the other regions covered in the report?

North America was the largest region in the lung cancer diagnostic and screening market in 2023. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the lung cancer diagnostic and screening market, request a sample here.

Who are the major players in the lung cancer diagnostic and screening market?

Major companies operating in the lung cancer diagnostic and screening market report are Pfizer Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories Inc., Medtronic Plc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, Eon Health Inc., OncimmuneHoldings Plc, Broncus Medical Inc., OncoCyte, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix, iDNA For further insights on the lung cancer diagnostic and screening market, request a sample here.

What are the key trends in the lung cancer diagnostic and screening market?

Major trend in the lung cancer diagnostic and screening market - Technological Innovations Reshape Landscape Of Lung Cancer Diagnostics And Screening Market. For further insights on the lung cancer diagnostic and screening market, request a sample here.

What are the major opportunities in the lung cancer diagnostic and screening market? What are the strategies for the lung cancer diagnostic and screening market?

For detailed insights on the major opportunities and strategies in the lung cancer diagnostic and screening market, request a sample here.

How does the lung cancer diagnostic and screening market relate to the overall economy and other similar markets?

For detailed insights on lung cancer diagnostic and screening market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the lung cancer diagnostic and screening industry?

For detailed insights on the mergers and acquisitions in the lung cancer diagnostic and screening industry, request a sample here.

What are the key dynamics influencing the lung cancer diagnostic and screening market growth? SWOT analysis of the lung cancer diagnostic and screening market.

For detailed insights on the key dynamics influencing the lung cancer diagnostic and screening market growth and SWOT analysis of the lung cancer diagnostic and screening industry, request a sample here.